Medicalgorithmics

Medicalgorithmics P/CF

The P/CF (Price-to-Cash-Flow Ratio) of Medicalgorithmics (MDG.WA) as of Nov 19, 2026 is -180.26. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was -25.11 — a change of 617.84% (lower).

P/CF

-180.26

YoY

617.84%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Medicalgorithmics is 2025 -180.26 . P/CF (Price-to-Cash-Flow Ratio) of Medicalgorithmics was 2024 -25.11 . It decreases by 617.84% lower compared to the previous year.

The Medicalgorithmics P/CF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/CF
Date
P/CF
Jan 1, 2018
7.43 PLN
Jan 1, 2019
24.33 PLN
Jan 1, 2020
-83.02 PLN
Jan 1, 2021
-50.69 PLN
Jan 1, 2022
51.88 PLN
Jan 1, 2023
1,804.62 PLN
Jan 1, 2024
-25.11 PLN
Jan 1, 2025
-180.26 PLN
The Medicalgorithmics P/CF history
YEARP/CFYoY
-180.26+617.84%
-25.11-101.39%
1,804.62+3,378.57%
51.88-202.34%
-50.69-38.94%
-83.02-441.23%
24.33+227.67%
7.43-35.32%
11.48+24.00%
9.26-51.10%
18.93-116.76%
-112.96—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medicalgorithmics Stock analysis

What does Medicalgorithmics do? Medicalgorithmics SA develops and manufactures the PocketECG system for remote heart arrhythmia diagnosis and monitoring, used in clinical drug trials for cardiac safety. The company provides IT and biotechnology services, scientific R&D in natural sciences, and works on tele-rehabilitation cardiology devices, hospital task optimization software, and remote ECG description systems. Its products serve healthcare providers, pharmaceutical companies conducting cardiac safety trials, and medical institutions requiring remote cardiac monitoring solutions. The firm operates through MEDICALGORITHMICS US HOLDING CORPORATION and Medi-Lynx Cardiac Monitoring LLC, offering diagnostic technology and related services to global healthcare markets. Medicalgorithmics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medicalgorithmics stock

P/CF (Price-to-Cash-Flow Ratio) of Medicalgorithmics is -180.26 in 2025.

P/CF (Price-to-Cash-Flow Ratio) of Medicalgorithmics changed from -25.11 to -180.26, representing a 617.84% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) Medicalgorithmics since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s Medicalgorithmics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Medicalgorithmics

All Key Metrics — Medicalgorithmics